(精编)【高血压英文教学精品课件】 Management of Hypertension.pptVIP

Management of Hypertension;The decline in age-adjusted mortality for stroke in the total population is 59.0%. *Age-adjusted to the 1940 U.S. census population.;The decline in age-adjusted mortality for CHD in the total population is 53.2%. *Age-adjusted to the 1940 U.S. census population.;Incidence of Reported End-Stage Renal Disease Therapy, 1982-1995;Awareness, Treatment, and Control of High Blood Pressure in Adults*;Hypertension;Blood Pressure Measurement ;Advantages of Self-Measurement;Ambulatory Measurement;Classification of Blood Pressure for Adults;Recommendations for Followup Based on Initial Measurements;Evaluation Objectives;Evaluation Components;Medical History;Physical Examination;Laboratory Tests and Other Diagnostic Procedures;Laboratory Tests Recommended Before Initiating Therapy;Optional Tests and Procedures;Hypertension;Examples of IdentifiableCauses of Hypertension;HTN: Renal Artery Stenosis;HTN: Hypersecretion of Aldosterone;HTN: Pheochromocytoma;Hypertension;HTN: Major Risk Factors;Hypertension: CAD Risk Factors;Target Organ DamageClinical Cardiovascular Disease;HTN: LVH;Fundoscopic Exam;Risk Stratification;Hypertension;Goal of HypertensionPrevention and Management;Treatment Strategies andRisk Stratification;Not at Goal Blood Pressure;HTN: TONE Study;HTN: TONE Study;Initial Drug Choices;Not at Goal Blood Pressure;Classes ofAntihypertensive Drugs;Initial Drug Choices*;JNC VI Treatment Algorithm;Treatment of Hypertension;HTN: Pharmacologic RxCompelling Indications;HTN: Patients with DM;HTN: Patients with CHF;HTN: Patients Post-MI;HTN: Older Patients;HTN: Older Patients;Systolic HTN: European Trial;Systolic HTN: European Trial;Hypertension in the Elderly;HTN: Older Patients;HTN: Pharmacologic RxSpecific Indications;HTN: Patients with CAD;HTN: Patients with LVH;HTN: LVH;HTN: Patients with LVH;;;HTN: Patients with Renal Insuficiency;HTN: Patients with Dyslipidemia;HTN: Patients with Dyslipidemia;Other Situations;Hype